Literature DB >> 8316298

An early pre-liver intraembryonic source of CFU-S in the developing mouse.

A L Medvinsky1, N L Samoylina, A M Müller, E A Dzierzak.   

Abstract

It is widely accepted that during murine embryogenesis, totipotent haematopoietic stem cells first originate in the yolk sac, then migrate to the fetal liver and finally colonize the bone marrow shortly before birth. This view is based on in vitro studies showing that yolk sac cells can differentiate into various haematopoietic lineages and in vivo studies showing that yolk sac contains spleen colony-forming units (CFU-S) beginning at day 8 of gestation. However, some investigators have failed to find statistically significant numbers of CFU-S arising from day 9 yolk sac and, although one group reported that yolk sac could repopulate the haematopoietic system of W mutant mice, others have failed to confirm yolk sac-derived repopulation of adults. In the avian and amphibian systems, the yolk sac gives rise only to early, transitory haematopoiesis whereas the definite adult haematopoietic stem cells in these vertebrates are derived from the mesodermal region containing the dorsal aorta. Because this analogous area of the mouse embryo has not been previously examined for haematopoietic activity, we directly compared the CFU-S activity of the aorta, gonad, mesonephros (AGM) region with the yolk sac and fetal liver during embryogenesis. Here we report that this intra-embryonic AGM region contains CFU-S activity at a higher frequency than that in embryonic yolk sac and that such activity appears in the AGM region before the fetal liver.

Entities:  

Mesh:

Year:  1993        PMID: 8316298     DOI: 10.1038/364064a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  89 in total

1.  B cells develop in the zebrafish pancreas.

Authors:  Nadia Danilova; Lisa A Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-07       Impact factor: 11.205

Review 2.  Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition.

Authors:  Igor I Slukvin
Journal:  FEBS Lett       Date:  2016-07-22       Impact factor: 4.124

Review 3.  Establishment and regulation of the HSC niche: Roles of osteoblastic and vascular compartments.

Authors:  Suleyman Coskun; Karen K Hirschi
Journal:  Birth Defects Res C Embryo Today       Date:  2010-12

Review 4.  Developmental relationship between hematopoietic and endothelial cells.

Authors:  Jesse J Lugus; Changwon Park; Kyunghee Choi
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

5.  Embryonic stromal clones reveal developmental regulators of definitive hematopoietic stem cells.

Authors:  Charles Durand; Catherine Robin; Karine Bollerot; Margaret H Baron; Katrin Ottersbach; Elaine Dzierzak
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-17       Impact factor: 11.205

Review 6.  Regulation of hematopoiesis and its interaction with stem cell niches.

Authors:  Fumio Arai; Atsushi Hirao; Toshio Suda
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

Review 7.  Blood cell generation from the hemangioblast.

Authors:  Christophe Lancrin; Patrycja Sroczynska; Alicia G Serrano; Arnaud Gandillet; Cristina Ferreras; Valerie Kouskoff; Georges Lacaud
Journal:  J Mol Med (Berl)       Date:  2009-10-25       Impact factor: 4.599

8.  Proteomics identifies multipotent and low oncogenic risk stem cells of the spleen.

Authors:  Francisco Dieguez-Acuña; Shohta Kodama; Yoshiaki Okubo; Ana Cristina Paz; Steven P Gygi; Denise L Faustman
Journal:  Int J Biochem Cell Biol       Date:  2009-12-18       Impact factor: 5.085

9.  The discovery of a source of adult hematopoietic cells in the embryo.

Authors:  Elaine Dzierzak; Alexander Medvinsky
Journal:  Development       Date:  2008-08       Impact factor: 6.868

Review 10.  Of lineage and legacy: the development of mammalian hematopoietic stem cells.

Authors:  Elaine Dzierzak; Nancy A Speck
Journal:  Nat Immunol       Date:  2008-02       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.